The pharmacy is accredited and I have verified that on the accreditor register.
I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious.
My background is quantitative but not chemical, so I can follow an equation more easily than a hand-wave.
What is the causal chain, and where does it stop being established?
Start with the regulatory basis, because compounding is permitted under specific conditions and those conditions are the whole subject.
Ask for the certificate of analysis on the compounded lot. A serious facility will have one; the request itself is informative.
| Dimension | 503A | 503B outsourcing facility |
|---|---|---|
| Prescription required | Patient-specific | Not required |
| cGMP compliance | Exempt | Required |
| Primary regulator | State board | FDA registration and inspection |
| Release testing | Generally none | Required |
| Operative standard | USP <795> / <797> | cGMP plus USP |
| Practical consequence | Potency varies between sites | Potency is tested before release |
Salt forms matter: a compounded preparation using a different salt from the approved product is not the same active moiety, and that has been the specific object of regulatory warnings.
Regulatory warnings have specifically addressed salt forms differing from the approved active moiety in this therapeutic area.
Nothing here is medical advice.
Ask which salt form. A different salt is a different active moiety.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsAnswering this needs the jurisdiction, since the framework differs substantially between countries and even between states.
Compounding is the preparation of a medicine for an individual patient in response to a prescription, where an approved product is unsuitable. It sits outside the approval framework by design rather than by omission.
The relevant detail is that regulators generally prohibit compounding what is essentially a copy of a commercially available product, with a shortage listing being the usual exception that permits it temporarily.
Beyond-use dating for compounded sterile preparations is governed by published standards keyed to the compounding environment.
The caveat is that the legal and regulatory position differs by jurisdiction and nothing here is legal advice.
Check the beyond-use date and what it was based on.
The part that matters: copies of commercially available products are generally not permitted, which is the constraint that shapes most of this market.
A compounded preparation has no marketing authorisation, no batch release by a qualified person and no pharmacovigilance obligation attached to it. That is the structural difference from a licensed product.
Specifically, additives are the other divergence. Preparations combining an active with vitamins or other agents are not equivalent to the approved product and have not been studied in that combination.
Prohibitions on compounding essential copies of commercially available products are explicit in the relevant regulatory frameworks, with shortage listings as the usual exception.
The framework is jurisdiction-specific. Check yours rather than a general answer.
edited 25 May 2025 by ilaria_bertone — tightened the wording; no substantive change
This is an area where the legal position and the quality question are separate and both matter.
Facility quality varies enormously and is the practical determinant of what you receive. The relevant questions are about sterility assurance, potency testing and beyond-use dating.
Compounding is defined in regulation as preparation for an individual patient under prescription and is distinguished from manufacturing by scale and by the patient-specific requirement.
Ask for the certificate of analysis on the lot. A serious facility has one.
The honest answer is that a well-run compounding pharmacy is a serious operation and that the variance across facilities is wide.
Beyond-use dates on compounded sterile preparations are set by standards that depend on the preparation environment and are much shorter than a manufactured product's shelf life.
Compounded means unapproved by definition. That is structural, not pejorative.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.